There’s no doubt that one of the most frightening things a pet owner can hear is that their animal companion has cancer. Animal Medical Center of Corona can help.
In order to best serve your pets in their hour of need, we’ve partnered with Torigen Pharmaceuticals, a pioneer in veterinary oncology, in the effort to administer ground-breaking tumor vaccines or immunotherapy, for pets suffering from certain forms of cancer.
These vaccines work by stimulating an immune response that targets cancer cells unique to the patient and are currently approved for use in dogs, cats, and horses. This emerging technology has proven remarkably successful in clinical trials with test subjects suffering only mild side effects.
- Step 1: Your AMC Corona veterinarian will surgically excise the tumor and overnight it to the Torigen lab.
- Step 2: The Torigen lab will prepare a personalized vaccine from the tumor, which will be sent back to AMC Corona within 72 hours.
- Step 3: Your AMC Corona veterinarian will administer the personalized vaccine by injection once a week for three weeks.
Like other forms of cancer therapy, such as chemotherapy and radiation, immunotherapy does not work on every patient, but it does give us more tools in our arsenal to fight cancer.
While we still recommend seeing an oncologist for many types of cancer and their appropriate therapies, immunotherapy can be useful in many cases. It is also much more economical than most of the other oncologic therapies available AND does not require going to a specialist.
Early Cancer Detection in Dogs with a Simple Blood Draw
OncoK9® is a first-in-class multi-cancer early detection (MCED) test.
Simple Blood Draw
Most cancer tests are either invasive (like a tissue biopsy) or require special equipment (like imaging). OncoK9 requires only a simple blood draw. The sample collection can take place during the same visit when the veterinarian prescribes the test.
OncoK9 has demonstrated cancer signal detection across more than 20 cancer types, including 7 of the most common cancers in dogs.
OncoK9 interrogates millions of cell-free DNA fragments in each blood sample, using sophisticated next-generation sequencing technology and bioinformatics algorithms to detect multiple classes of genomic alterations associated with cancer.
By identifying cancer signal in cell-free DNA extracted from a blood sample, OncoK9 may allow for earlier detection of cancer, before the onset of clinical signs.
The OncoK9® Test
The OncoK9 liquid biopsy test uses a simple blood draw to detect abnormal DNA released into circulation by cancer cells. The test sorts through millions of DNA fragments in each sample, using powerful next-generation sequencing (NGS) technology to identify cancer-associated genomic alterations in dogs and enable veterinarians to detect cancer earlier and manage it more effectively.
– There are 6 million new cancer cases per year in dogs
– Cancer is by far the biggest threat to dogs and is the #1 cause of death
– 1 in 3 dogs have a lifetime risk of cancer
– Dogs over age 8 have a 7x higher risk of cancer
– Predisposed breeds at younger ages have a higher risk of cancer
When to Use OncoK9®
OncoK9 is a multi-cancer early detection (MCED) test for the detection and characterization of cancer-associated genomic alterations in DNA isolated from canine whole blood samples, using next-generation sequencing (NGS) technology. OncoK9 is intended for use in dogs who are at higher risk of cancer.
OncoK9 is recommended as an annual screening test for all dogs starting at 8 years of age, and potentially at younger ages for dogs belonging to breeds that are predisposed to cancer.
OncoK9 is also recommended as an aid-in-diagnosis for dogs in which cancer is suspected based on clinical signs or other clinical findings.
It’s important to know that should your pet contract cancer, it is not automatically a terminal diagnosis. Our team is here for you and can offer hope and healing in many cases. Call (951) 493-6771 for more information or a consultation today.